US-based external-beam theranostic oncology company, RefleXion, has announced that its radiotherapy device RefleXion X1 has been used as part of a worlds first combination of therapies including ...

HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a theranostic oncology company, today announced the appointment of Steve Schoch as chief financial officer (CFO) and the promotion of Phil Aulson ...

"We are very pleased to have begun patient treatments on the RefleXion X1 platform," said Ari Gabayan, M.D., medical director at Beverly Hills Cancer Center. "This ...

HAYWARD, Calif.--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company, today announced the initial closing of a $105M equity raise, led by The Rise Fund, TPG’s multi-sector global impact ...

Just over a year after being recognized by the FDA for the potential “breakthrough” nature of its radiation therapy technology, RefleXion Medical has gotten the go-ahead from the agency to begin ...

RefleXion Medical is all-in on its biology-guided radiotherapy (BgRT) system—so much so, in fact, that the startup has more than doubled its existing debt to prepare for the technology’s commercial ...

We met Reflexion and its Edge screen last year, and even then we were pretty taken with the idea: A Whac-A-Mole-style test for athletes that improves coordination and helps spot concussions after a ...